Dr. Carlos Manuel Gadea is a rheumatologist in Montgomery,Alabama.
Male
1417141763
| Description | # of Times Performed | # of Patients | Average Charge ($) |
|---|---|---|---|
| Aspiration and/or injection of large joint or joint capsule | 40.0 | 23.0 | 114.0 |
| Blood test, comprehensive group of blood chemicals | 389.0 | 247.0 | 27.0 |
| Automated urinalysis test | 56.0 | 39.0 | 6.0 |
| Aldolase (enzyme) level | 19.0 | 12.0 | 24.0 |
| Vitamin D-3 level | 42.0 | 35.0 | 74.0 |
| Creatine kinase (cardiac enzyme) level | 21.0 | 14.0 | 17.0 |
| Creatinine level to test for kidney function or muscle injury | 58.0 | 40.0 | 13.0 |
| G6PD (enzyme) level | 11.0 | 11.0 | 24.0 |
| Analysis of substance using immunoassay technique | 26.0 | 12.0 | 30.923076923 |
| Parathormone (parathyroid hormone) level | 17.0 | 17.0 | 102.0 |
| Total protein level, urine | 58.0 | 40.0 | 10.0 |
| Protein measurement, serum | 37.0 | 30.0 | 36.0 |
| Thyroglobulin (thyroid related hormone) level | 29.0 | 29.0 | 33.0 |
| Blood test, thyroid stimulating hormone (TSH) | 11.0 | 11.0 | 42.0 |
| Uric acid level, blood | 32.0 | 24.0 | 12.0 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 356.0 | 225.0 | 20.0 |
| Clotting factor X assessment test | 23.0 | 23.0 | 20.0 |
| Red blood cell sedimentation rate, to detect inflammation | 270.0 | 189.0 | 7.0 |
| Screening test for autoimmune disorder | 44.0 | 43.0 | 30.0 |
| Measurement of antibody for assessment of autoimmune disorder | 17.0 | 16.0 | 28.0 |
| Measurement C-reactive protein for detection of infection or inflammation | 249.0 | 175.0 | 13.0 |
| Beta 2 glycoprotein 1 antibody (autoantibody) measurement | 63.0 | 23.0 | 63.0 |
| Cardiolipin antibody (tissue antibody) measurement | 63.0 | 21.0 | 63.0 |
| Measurement of complement (immune system proteins) | 135.0 | 46.0 | 30.0 |
| Measurement of antibody for rheumatoid arthritis assessment | 71.0 | 71.0 | 32.0 |
| Measurement of DNA antibody | 105.0 | 82.0 | 34.0 |
| Measurement of antibody for assessment of autoimmune disorder | 248.0 | 62.0 | 45.0 |
| Screening test for antibody to noninfectious agent | 40.0 | 38.0 | 36.0 |
| Immunologic analysis technique on serum | 37.0 | 30.0 | 46.0 |
| Microsomal antibodies (autoantibody) measurement | 29.0 | 29.0 | 36.0 |
| Rheumatoid factor analysis | 66.0 | 66.0 | 14.0 |
| Tuberculosis test | 18.0 | 18.0 | 154.0 |
| Hepatitis B core antibody (IgM) measurement | 24.0 | 24.0 | 30.0 |
| Thyroglobulin (thyroid protein) antibody measurement | 29.0 | 29.0 | 32.0 |
| Hepatitis C antibody measurement | 41.0 | 41.0 | 36.0 |
| Detection test for Hepatitis B surface antigen | 41.0 | 41.0 | 26.0 |
| Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 34.0 | 17.0 | 44.0 |
| New patient office or other outpatient visit, typically 45 minutes | 109.0 | 109.0 | 311.0 |
| Established patient office or other outpatient visit, typically 15 minutes | 67.0 | 54.0 | 139.97014925 |
| Established patient office or other outpatient, visit typically 25 minutes | 471.0 | 278.0 | 203.29936306 |
| Injection, denosumab, 1 mg | 1140.0 | 15.0 | 32.0 |
| Injection, methylprednisolone acetate, 40 mg | 25.0 | 16.0 | 7.22 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 132.0 | 16.0 | 4.0 |
Cookies on this website are used to improve your experience and display advertising. You agree to the use of cookies by continuing to use this website. Our Privacy Policy contains more information about how we use cookies.